Mark Davis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:OMF

Mark M. Davis, PhD, is a Professor of Microbiology and Immunology and the Director of the Stanford Institute for Immunity, Transplantation and Infection at Stanford University School of Medicine.[1] He is on the ME/CFS Advisory Board of the Stanford ME/CFS Initiative.[2]

Education[edit | edit source]

  • Ph.D., Caltech, Molecular Biology (1981)
  • B.A., The Johns Hopkins University, Molecular Biology (1974)

ME/CFS research[edit | edit source]

Professor Mark Davis, along with Dr. Jose Montoya and many colleagues from several universities, are involved with the study of cytokines as a potential diagnostic biomarker of ME/CFS disease severity[3], as well as, differentiating between ME/CFS patients and sedentary controls.[4]

Notable studies on ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

Learn more[edit | edit source]

Mark Davis Stanford Bio

See also[edit | edit source]

References[edit | edit source]

  1. https://med.stanford.edu/profiles/mark-davis
  2. http://med.stanford.edu/chronicfatiguesyndrome/about/team.html
  3. Chronic fatigue syndrome research at Stanford - Stanford Medicine Spring 2016 - By: Kris Newby
  4. 4.04.1 Moneghetti, Kegan J.; Skhiri, Mehdi; Contrepois, Kévin; Kobayashi, Yukari; Maecker, Holden T.; Davis, Mark M.; Snyder, Michael; Haddad, Francois; Montoya, Jose G. (2018), "Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Scientific Reports, 8, doi:10.1038/s41598-018-20941-w 
  5. Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017), "Cytokine signature associated with disease severity in chronic fatigue syndrome patients", Proceedings of the National Academy of Sciences of the United States of America, 114 (34): E7150-E7158, doi:10.1073/pnas.1710519114 

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.